X0306 4 2015-04-07 0 0001488613 Foundation Medicine, Inc. FMI 0001020741 JONES EVAN/ FA C/O FOUNDATION MEDICINE, INC. 150 SECOND STREET CAMBRIDGE MA 02141 1 0 0 0 Common Stock 2015-04-07 4 U 0 8131 50.00 D 1945 D Common Stock 2015-04-07 4 U 0 44634 50.00 D 10675 I by jVen Capital, LLC The amount reported represents the estimated number of shares sold by the reporting person in connection with the tender offer for shares of Common Stock of the Issuer (the "Tender Offer") by Roche Holdings, Inc. ("Roche"). Roche will purchase only a prorated portion of the shares properly tendered by each tendering stockholder. Based on a preliminary count reported by Roche, the preliminary proration factor for the Tender Offer is approximately 80.7%. If necessary, an amended Form 4 will be filed to report the number of shares actually sold by the reporting person in connection with the Tender Offer once the final proration factor is determined. Shares held by jVen Capital, LLC, of which the reporting person is the managing member. /s/ Robert W. Hesslein, as Attorney-in-Fact 2015-04-09